10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 149,002 | 172,908 | 154,883 | 165,021 | 151,654 |
| Cost of Goods | 48,695 | 47,824 | 49,438 | 54,066 | 45,261 |
| Gross Profit | 100,307 | 125,084 | 105,445 | 110,955 | 106,393 |
| Operating Expenses | 133,244 | 95,782 | 145,211 | 160,860 | 148,139 |
| Operating Income | -32,242 | 30,126 | -39,328 | -49,839 | -41,485 |
| Interest Expense | -3 | 3 | 0 | 0 | 2 |
| Other Income | 4,034 | 6,874 | 5,822 | 1,459 | 7,049 |
| Pre-tax Income | -28,205 | 36,997 | -33,506 | -48,380 | -34,438 |
| Income Tax | -733 | 2,459 | 852 | 648 | 1,315 |
| Net Income Continuous | -27,472 | 34,538 | -34,358 | -49,028 | -35,753 |
| Net Income | $-27,472 | $34,538 | $-34,358 | $-49,028 | $-35,753 |
| EPS Basic Total Ops | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 |
| EPS Basic Continuous Ops | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 |
| EPS Diluted Total Ops | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 |
| EPS Diluted Continuous Ops | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.22 | 0.28 | -0.36 | -0.40 | -0.30 |
| EBITDA(a) | $-19,177 | $39,777 | $-29,514 | $-41,729 | $-28,281 |